Sigma Healthcare Shares Face Monday Test as Boots Deal Drama Hits ASX:SIG
Sigma Healthcare shares closed at A$2.64 Friday, down 1.86%, as the S&P/ASX 200 rose nearly 2%. Reports say investor pushback has cooled Sigma’s interest in acquiring UK pharmacy chain Boots. The company has not updated the market since June 10, when it confirmed preliminary talks. Investors remain focused on the risks of a large overseas deal and Sigma’s UK expansion plans.